Is Esperion Therapeutics, Inc. (ESPR) a Buy, Sell, or Hold?
Esperion Therapeutics, Inc.
NASDAQ:ESPR
$3.18 USD
$0 (0.0%)
- Volume
- 59.09M
- Average Volume
- 15.48M
- Market Capitalization
- $661.15M
- P/E Ratio
- -131.40
- Dividend Yield
- 99.37%
- Price Target
- $3.16
- Year High
- $4.18
- Year Low
- $1.10
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.53
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
0.89%
Investors Holding
7
change: -211 | last: 218
Increased Positions
2
change: -102 | last: 104
Reduced Positions
2
change: -59 | last: 61
New Positions
1
change: -38 | last: 39
Sold Positions
201
change: 167 | last: 34
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -25.9292 | last: 0.2593
Total Invested
6.99M
ESPR Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $3.70 | 207.87M | $769.1M | $167.85M | $548M | $1.15B |
| 2024-12-31 | $2.20 | 187.18M | $411.8M | $144.76M | $591.21M | $858.25M |
| 2023-12-31 | $2.99 | 103.11M | $308.29M | $82.25M | $540.95M | $766.99M |
| 2022-12-31 | $6.23 | 66.41M | $413.72M | $124.78M | $260.95M | $549.89M |
| 2021-12-31 | $5.00 | 28.9M | $144.51M | $208.89M | $260.2M | $195.82M |
| 2020-12-31 | $26.00 | 27.47M | $714.32M | $304.96M | $185.41M | $594.77M |
| 2019-12-31 | $59.63 | 27.09M | $1.62B | $166.13M | $1.56M | $1.45B |
| 2018-12-31 | $46.00 | 26.75M | $1.23B | $36.97M | $- | $1.19B |
| 2017-12-31 | $65.84 | 23.93M | $1.58B | $34.47M | $1.04M | $1.54B |
| 2016-12-31 | $12.52 | 22.54M | $282.26M | $38.16M | $2.73M | $246.82M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2.74 | 251.35M | $688.71M | $156.16M | $543.81M | $1.08B |
| 2025-12-31 | $3.70 | 236.68M | $875.73M | $167.85M | $548M | $1.26B |
| 2025-09-30 | $2.65 | 198.15M | $525.11M | $92.45M | $600.98M | $1.03B |
| 2025-06-30 | $0.98 | 196.84M | $193.77M | $86.06M | $598.18M | $705.89M |
| 2025-03-31 | $1.44 | 196.13M | $282.42M | $114.63M | $297.78M | $465.58M |
| 2024-12-31 | $2.20 | 195.57M | $430.25M | $144.76M | $297.6M | $583.09M |
| 2024-09-30 | $1.65 | 194.93M | $321.64M | $144.72M | $268.96M | $445.88M |
| 2024-06-30 | $2.34 | 188.79M | $441.78M | $189.3M | $269.14M | $521.61M |
| 2024-03-31 | $2.79 | 169.26M | $472.23M | $226.61M | $548.87M | $794.49M |
| 2023-12-31 | $2.99 | 112.4M | $336.09M | $82.25M | $540.95M | $794.79M |
| 2023-09-30 | $0.98 | 111.87M | $109.63M | $114.83M | $301.14M | $295.94M |
| 2023-06-30 | $1.39 | 109.24M | $151.85M | $138.47M | $285.91M | $299.29M |